Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
3.890
-0.070 (-1.77%)
At close: Apr 28, 2026, 4:00 PM EDT
3.950
+0.060 (1.54%)
After-hours: Apr 28, 2026, 6:12 PM EDT
Sensus Healthcare Revenue
In the year 2025, Sensus Healthcare had annual revenue of $27.48M, down -34.26%. Sensus Healthcare had revenue of $4.94M in the quarter ending December 31, 2025, a decrease of -62.20%.
Revenue (ttm)
$27.48M
Revenue Growth
-34.26%
P/S Ratio
2.33
Revenue / Employee
$458,033
Employees
60
Market Cap
64.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.48M | -14.33M | -34.26% |
| Dec 31, 2024 | 41.81M | 17.40M | 71.31% |
| Dec 31, 2023 | 24.41M | -20.13M | -45.20% |
| Dec 31, 2022 | 44.53M | 17.49M | 64.68% |
| Dec 31, 2021 | 27.04M | 17.47M | 182.36% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Xtant Medical Holdings | 133.93M |
| Pulmonx | 90.50M |
| LENSAR | 58.44M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
| InspireMD | 8.98M |
SRTS News
- 5 days ago - Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026 - Business Wire
- 4 weeks ago - Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract - Business Wire
- 2 months ago - Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base - Business Wire
- 2 months ago - Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology - Business Wire
- 2 months ago - Sensus Healthcare Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer - Business Wire
- 2 months ago - Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026 - Business Wire
- 3 months ago - Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco - Business Wire